Prot #M23-703: A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusActive
Effective start/end date10/2/2410/2/25

Funding

  • AbbVie Inc. (Prot #M23-703)